Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.| www.targetedonc.com
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.| www.targetedonc.com
A phase 2 study reveals autologous TIL therapy's potential to stabilize recurrent head and neck cancer, offering hope for improved treatment options.| www.targetedonc.com
Robert L. Ferris, MD, PhD, pens this month's editor-in-chief column for Targeted Therapies in Oncology.| Targeted Oncology
Robert L. Ferris, MD, PhD, editor-in-chief of Targeted Therapies in Oncology, discusses his monthly column in this episode of Chief Insights in Oncology.| Targeted Oncology
